First reported case of diabetes mellitus type 1 as a possible secondary autoimmune disease following alemtuzumab treatment in MS

J Neurol. 2014 Oct;261(10):2016-8. doi: 10.1007/s00415-014-7448-y. Epub 2014 Aug 1.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Adult
  • Alemtuzumab
  • Antibodies, Monoclonal, Humanized / adverse effects*
  • Antineoplastic Agents / adverse effects*
  • Autoantibodies / blood
  • Diabetes Mellitus / physiopathology*
  • Female
  • Graves Disease / chemically induced*
  • Humans
  • Multiple Sclerosis / complications
  • Multiple Sclerosis / drug therapy

Substances

  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Autoantibodies
  • Alemtuzumab